Scientific Advisory Board

Co-chair

Elizabeth Eisenhauer, MD
Elizabeth Eisenhauer, Co-Chair, Canadian Cancer Research Alliance;
Elizabeth Eisenhauer, Chair, Canadian Partnership Against Cancer's Research Advisory Group ;
Elizabeth Eisenhauer, Director, Investigational New Drug Program - NCIC Clinical Trials Group;
Elizabeth Eisenhauer, Professor, Department of Oncology, Queen's University
Eric Lander, PhD
Eric S. Lander, Professor of Biology, Massachusetts Institute of Technology (MIT);
Eric S. Lander, Founding Director, Broad Institute;
Eric S. Lander, Member of, Whitehead Institute for Biomedical Research, MIT;
Eric S. Lander, Professor of Systems Biology, Harvard Medical School

Member

Lewis Cantley, PhD
Lewis Cantley, Chief, Beth Israel Deaconess Medical Center;
Lewis Cantley, Professor of Systems Biology, Beth Israel Deaconess Medical Center
Arul Chinnaiyan, MD
Arul Chinnaiyan, Professor of Pathology and Urology, University of Michigan Medical School;
Arul Chinnaiyan, Investigator, Howard Hughes Medical Institute;
Arul Chinnaiyan, Director of Cancer Bioinformatics, University of Michigan Medical School;
Arul Chinnaiyan, Director of Pathology Research Informatics, University of Michigan Medical School
Karen Gelmon, MD
Karen Gelmon, Senior Scientist, BC Cancer Agency
Tak Mak, PhD
Tak Mak, Senior Scientist, Division of Stem Cell and Developmental Biology Advanced Medical Discovery Institute/Ontario Cancer Institute;
Tak Mak, Director, The Campbell Family Institute for Breast Cancer Research
David Mankoff, MD
David Mankoff, Professor Radiology, Medicine and Bioengineering, University of Washington
Harold Moses, MD
Harold L. Moses, Professor of Cancer Biology, Vanderbilt-Ingram Cancer Center;
Harold L. Moses, Director, Hortense B. Ingram;
Harold L. Moses, VICC Member Researcher, Vanderbilt-Ingram Cancer Center;
Harold L. Moses, Professor of Medicine and Pathology, Vanderbilt-Ingram Cancer Center
Homer Pearce, PhD
Homer Pearce, Board of Directors, Eli Lilly and Company;
Homer Pearce, Director, Sunesis Pharmaceuticals Inc.
Richard Schilsky, MD
Richard Schilsky, Professor of Medicine, University of Chicago;
Richard Schilsky, Chairman, Cancer and Leukemia Group B, University of Chicago;
Richard Schilsky, Associate Dean for Clinical Research, University of Chicago
Jane Weeks, MD
Jane Weeks, Professor, Department of Health Policy and Management, Harvard School of Public Health, Dana-Farber Cancer Institute ;
Jane Weeks, Professor, Department of Medicine, Harvard Medical School